A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

Name: A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form
Published: 2024
License: Public Domain

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

atrial-fibrillation

atrial fibrillation, atrial flutter, refralon, cavutilide, niferidil, class iii antiarrhythmic drug, new russian drug, atrial fibrillation (af), tablet, atrial flutter (afl), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

Related documents